Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
Crossref DOI link: https://doi.org/10.1007/s10875-014-0070-z
Published Online: 2014-07-01
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dorsey, Morna J.
Ho, Viet
Mabudian, Mohsen
Soler-Palacín, Pere
Domínguez-Pinilla, Nerea
Rishi, Radha
Rishi, Rahul
Wong, Duane
Rojavin, Mikhail
Hubsch, Alphonse
Berger, Melvin
License valid from 2014-07-01